SCOTTSDALE, AZ -- (MARKET WIRE) -- April 24, 2007 -- IR BioSciences Holdings, Inc. (OTCBB: IRBO) announced today that it has appointed Robert J. Hariri, M.D., Ph.D. to its Board of Directors. Dr. Hariri is the Chief Executive Officer, of Celgene Cellular Therapeutics, a division of Celgene Corp., a world leader in human cellular and tissue therapeutics and a company with a market capitalization of more than $21 Billion. Dr. Hariri is a highly successful entrepreneur, has extensive experience in the capital markets and in developing start-up companies into highly successful commercial operations. He also has been extensively published in leading medical and scientific publications. This year he was named the National Multiple Sclerosis Pharmaceutical Executive of the Year. Last year, he was the recipient of the Thomas Alva Edison Patent Award. He has also received many other awards for his medical and entrepreneurial accomplishments.
